Cybermed USA is categorized under Research and Development Laboratories in Irvine, CA and active since 2009.
Cybermed USA was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5415110 by the NAICS.
If you are seeking more information, feel free to contact Cheol Young Kim at the company’s single location by writing to 310 Goddard # 250, Irvine, California CA 92618 or by phoning (949) 341-0623. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cybermed USA |
| Contact Person: | Cheol Young Kim |
| Address: | 310 Goddard # 250, Irvine, California 92618 |
| Phone Number: | (949) 341-0623 |
| Website Address: | ondemand3d.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 5415110 |
| Share This Business: |
Cybermed USA was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5415110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Cheol Young Kim for inquiries that concern Cybermed USA by calling the company number (949) 341-0623, as your correspondence is most welcome. Additionally, the physical location of the single location of Cybermed USA can be found at the coordinates 33.63261,-117.74122 as well as the street address 310 Goddard # 250 in Irvine, California 92618.
For its online presence, you may visit Cybermed USA’s website at ondemand3d.com and engage with its social media outlets through on Twitter and on Facebook.